Vedolizumab more likely to be discontinued than ustekinumab in anti-TNF-experienced patients with fistulizing Crohn’s disease

por Newman, Kira L., Johnson, Laura A., Stidham, Ryan W., Higgins, Peter D. R.
Publicado 2023

Molecular imaging biomarkers for cell-based immunotherapies

por Haris, Mohammad, Bagga, Puneet, Hariharan, Hari, McGettigan-Croce, Bevin, Johnson, Laura A., Reddy, Ravinder
Publicado 2017

Specific increase in T cell potency via structure-based design of a T cell receptor for adoptive immunotherapy

por Malecek, Karolina, Grigoryan, Arsen, Zhong, Shi, Gu, Wei Jun, Johnson, Laura A, Rosenberg , Steven A, Cardozo, Timothy, Krogsgaard, Michelle
Publicado 2014

A melanocyte lineage program confers resistance to MAP kinase pathway inhibition

por Johannessen, Cory M., Johnson, Laura A., Piccioni, Federica, Townes, Aisha, Frederick, Dennie T., Donahue, Melanie K., Narayan, Rajiv, Flaherty, Keith T., Wargo, Jennifer A., Root, David E., Garraway, Levi A.
Publicado 2013

The role of the innate immune response regulatory gene ABCF1 in mammalian embryogenesis and development

por Wilcox, Sara M., Arora, Hitesh, Munro, Lonna, Xin, Jian, Fenninger, Franz, Johnson, Laura A., Pfeifer, Cheryl G., Choi, Kyung Bok, Hou, Juan, Hoodless, Pamela A., Jefferies, Wilfred A.
Publicado 2017

Myeloablative Temozolomide Enhances CD8(+) T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice

por Sanchez-Perez, Luis A., Choi, Bryan D., Archer, Gary E., Cui, Xiuyu, Flores, Catherine, Johnson, Laura A., Schmittling, Robert J., Snyder, David, Herndon, James E., Bigner, Darell D., Mitchell, Duane A., Sampson, John H.
Publicado 2013

T cell receptor affinity and avidity defines antitumor response and autoimmunity in T cell immunotherapy

por Krogsgaard, Michelle, Zhong, Shi, Malecek, Karolina, Johnson, Laura A, Yu, Zhiya, Vega-Saenz de Miera, Eleazar, Darvishian, Farbod, McGary-Shipper, Katelyn, Huang, Kevin, Boyer, Joshua, Corse, Emily, Shao, Yongzhao, Rosenberg, Steven A, Restifo, Nicholas P, Osman, Iman
Publicado 2013

EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma

por Miao, Hongsheng, Choi, Bryan D., Suryadevara, Carter M., Sanchez-Perez, Luis, Yang, Shicheng, De Leon, Gabriel, Sayour, Elias J., McLendon, Roger, Herndon, James E., Healy, Patrick, Archer, Gary E., Bigner, Darell D., Johnson, Laura A., Sampson, John H.
Publicado 2014

Engineering the immune response to "self" for effective cancer immunotherapy

por Zhong, Shi, Malecek, Karolina, Moogk, Duane, Johnson, Laura A, Yu, Zhiya, Grigoryan, Arsen, Vega-Saenz de Miera, Eleazar, Darvishian, Farbod, Gu, Wei Jun, McGary, Katelyn, Huang, Kevin, Boyer, Joshua, Corse, Emily, Yongzhao, Shao, Rosenberg, Steven A, Restifo, Nicholas P, Cardozo, Timothy, Frey, Alan, Osman, Iman, Krogsgaard, Michelle
Publicado 2014

The SETDB1 histone methyltransferase is recurrently amplified in and accelerates melanoma

por Ceol, Craig J., Houvras, Yariv, Jane-Valbuena, Judit, Bilodeau, Steve, Orlando, David A., Battisti, Valentine, Fritsch, Lauriane, Lin, William M., Hollmann, Travis J., Ferré, Fabrizio, Bourque, Caitlin, Burke, Christopher J., Turner, Laura, Uong, Audrey, Johnson, Laura A., Beroukhim, Rameen, Mermel, Craig H., Loda, Massimo, Ait-Si-Ali, Slimane, Garraway, Levi A., Young, Richard A., Zon, Leonard I.
Publicado 2011

Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma

por Johnson, Laura A, Scholler, John, Ohkuri, Takayuki, Kosaka, Akemi, Patel, Prachi R, McGettigan, Shannon E, Nace, Arben, Thekkat, Pramod, Loew, Andreas, Chen, Taylor J, Fraietta, Joseph A, Posey, Avery D, Boesteanu, Alina C, Cogdill, Alexandria P, Engels, Boris, Singh, Reshma, Ezell, Tucker R, Idamakanti, Neeraja, Plesa, Gabriela, Seykora, John, Okada, Hideho, June, Carl, Brogdon, Jennifer, Maus, Marcela
Publicado 2014

Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas

por Yin, Yibo, Boesteanu, Alina C., Binder, Zev A., Xu, Chong, Reid, Reiss A., Rodriguez, Jesse L., Cook, Danielle R., Thokala, Radhika, Blouch, Kristin, McGettigan-Croce, Bevin, Zhang, Logan, Konradt, Christoph, Cogdill, Alexandria P., Panjwani, M. Kazim, Jiang, Shuguang, Migliorini, Denis, Dahmane, Nadia, Posey, Avery D., June, Carl H., Mason, Nicola J., Lin, Zhiguo, O’Rourke, Donald M., Johnson, Laura A.
Publicado 2018

COT/MAP3K8 drives resistance to RAF inhibition through MAP kinase pathway reactivation

por Johannessen, Cory M., Boehm, Jesse S., Kim, So Young, Thomas, Sapana R., Wardwell, Leslie, Johnson, Laura A., Emery, Caroline M., Stransky, Nicolas, Cogdill, Alexandria P., Barretina, Jordi, Caponigro, Giordano, Hieronymus, Haley, Murray, Ryan R., Salehi-Ashtiani, Kourosh, Hill, David E., Vidal, Marc, Zhao, Jean J., Yang, Xiaoping, Alkan, Ozan, Kim, Sungjoon, Harris, Jennifer L., Wilson, Christopher J., Myer, Vic E., Finan, Peter M., Root, David E., Roberts, Thomas M., Golub, Todd, Flaherty, Keith T., Dummer, Reinhard, Weber, Barbara, Sellers, William R., Schlegel, Robert, Wargo, Jennifer A., Hahn, William C., Garraway, Levi A.
Publicado 2010